AwesomeCapital
Monday, November 4, 2019
Turning Point Therapeutics EPS misses by $0.07
Turning Point Therapeutics (NASDAQ:
TPTX
): Q3 GAAP EPS of -$0.63
misses by $0.07
.
Cash, cash equivalents and marketable securities of $423.6M.
Press Release
https://seekingalpha.com/news/3513952-turning-point-therapeutics-eps-misses-0_07
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.
‹
›
Home
View web version
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.